Antiviral Activity of Oral Probiotics
Lower Respiratory Tract Infection, Upper Respiratory Tract Infection
About this trial
This is an interventional basic science trial for Lower Respiratory Tract Infection focused on measuring Streptococcus salivarius K12, Probiotic, Antiviral activity, Antibacterial activity, microbial colonization, oral probiotic, powder, prebiotic
Eligibility Criteria
Inclusion criteria:
- In general good health 18 - 80 years of age.
- Practice good oral hygiene.
Exclusion criteria:
- Have a history of autoimmune disease or are immunocompromised.
- Are on concurrent antibiotic therapy or regular antibiotic use within last 1 week
- History of allergy (e.g. dairy).
Sites / Locations
- Blis Technologies LtdRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Streptococcus salivarius K12
Streptococcus salivarius K12 with a prebiotic included
Streptococcus salivarius M18
Streptococcus salivarius M18 with a prebiotic included
Streptococcus salivarius K12 (Dose 1: 1 Billion colony forming units /g)
Streptococcus salivarius K12 (Dose 1: 1 Billion colony forming units /g)
Streptococcus salivarius M18 (Dose 1: 1 Billion colony forming units /g)
Streptococcus salivarius M18 (Dose 1: 1 Billion colony forming units /g)